Related Articles
Paclitaxel in anthracycline-treated breast cancer patients.
The impact of schedule on acute toxicity and dose-intensity of high-dose chemotherapy with epirubicin and cyclophosphamide plus colony stimulating factors in advanced breast cancer.
THE USE OF PERIPHERAL-BLOOD HEMATOPOIETIC PROGENITORS MOBILIZED WITH STANDARD-DOSE CHEMOTHERAPY PLUS GRANULOCYTE-COLONY-STIMULATING FACTOR TO SUPPORT MULTICYCLIC DOSE-INTENSIVE CHEMOTHERAPY FOR ADVANCED BREAST-CANCER
ADVANCED BREAST-CANCER - A RANDOMIZED STUDY OF DIFFERENT DOSES OF EPIRUBICIN ASSOCIATED WITH FIXED DOSES OF CYCLOPHOSPHAMIDE AND 5-FLUOROURACIL
Multicyclic dose-intensive chemotherapy with circulating progenitor cell support for high-risk primary breast cancer.